\subsection{Table 6}
\textbf{\textit{Table---6 Separating Research Firms with high and low net income}} \\
\begin{tabular}{lcccc}
 \hline \hline
&Low net &High net & Low net & High net \\
&income&income&income&income
\\ \hline
Date &0.003 &0.011\\
&&[0.011] &[0.008]\\
No specifiable lead product&0.171 &0.070 &0.200 &0.092\\
&[0.070]**& [0.068] &[0.076]***& [0.074]\\
Unknown if specifiable lead product&0.029 &-0.036 &0.040 &-0.038\\
&[0.104]& [0.097] &[0.114]& [0.110]\\
Agreement involves diagnostic product&-0.073 &-0.084 &-0.073 &-0.074\\
&[0.090]& [0.087]& [0.097] &[0.103]\\
Agreement involves veterinary product &-0.106 &-0.126 &-0.096 &-0.146\\
&[0.132]& [0.126] &[0.147] &[0.148]\\
Carter-Manaster rank of lead underwriter of research &0.018& 0.007 &0.017 &0.005\\
\quad firm`s IPO &[0.016]& [0.015]&[0.017] &[0.017]\\
Number of patents research firm &0.001 &0.004 &0.001 &0.003 \\ 
&[0.001]& [0.004]& [0.001]& [0.004]\\
Financial Health Index&0.035& 0.080 &0.099 &0.098\\
&[0.126]& [0.101]& [0.141] &[0.116]\\
Number of previous research agreements between&-0.030& 0.021 &-0.078 &0.055 \\
\quad financing and research firms&[0.067] &[0.089] &[0.073] &[0.101]\\
\\
Constant &-6.869 &-22.205 &0.125& 0.101\\
&[22.562] &[15.196] &[0.589]& [0.561]\\
\\
Year fixed effects&&&X&X\\
Financing firm fixed effects&&&X&X\\
Observations& 249 &234 &249 &234\\
$R^2$&0.05 &0.04 &0.13 &0.14\\



\hline

\end{tabular}
\input{Notes}